Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Carola Schiller"'
Autor:
Adyary Fallarero, Gulsah Bayraktar, Pia Vuorela, Carola Schiller, Ezgi Turunc, Manuel Krug, Sülünay Parlar, Guliz Armagan, Ayfer Yalcin, Vildan Alptüzün, Christoph A. Sotriffer, Kristina Leuner, Daniela Karlsson, Malgorzata Burek, Michaela Prinz, Ulrike Holzgrabe, Ercin Erciyas, Carola Förster
Publikováno v:
European Journal of Pharmaceutical Sciences. 49:603-613
Given the fundamentally multifactorial character of Alzheimer's disease (AD), addressing more than one target for disease modification or therapy is expected to be highly advantageous. Here, following the cholinergic hypothesis, we aimed to inhibit b
Autor:
Michael Willem, Sören Mai, Angelo Occhipinti, Stephan Dröse, Schamim H. Eckert, Ulrich Brandt, Carola Schiller, Richard D. Palmiter, Gunter P. Eckert, Ilka Wittig, Shane E. Kruse, Tanja Schütt, Kristina Leuner, Christian Haass, Christopher Kurz, Walter E. Müller, Marina Jendrach, Andreas S. Reichert
Publikováno v:
Antioxidants & Redox Signaling, 16, 1421-33
Antioxidants & redox signaling 16(12), 1421-1433 (2012). doi:10.1089/ars.2011.4173
Antioxidants & Redox Signaling, 16, 12, pp. 1421-33
Antioxidants & redox signaling 16(12), 1421-1433 (2012). doi:10.1089/ars.2011.4173
Antioxidants & Redox Signaling, 16, 12, pp. 1421-33
Item does not contain fulltext AIMS: Intracellular amyloid beta (Abeta) oligomers and extracellular Abeta plaques are key players in the progression of sporadic Alzheimer's disease (AD). Still, the molecular signals triggering Abeta production are la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::740a4dd8a5748d77110e784a234adbea
http://hdl.handle.net/2066/108688
http://hdl.handle.net/2066/108688